The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for ...

Preetika Rana is an award-winning reporter for The Wall Street Journal in San Francisco with experience reporting from six ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Christian Happi, a distinguished professor of molecular biology and genomics of infectious diseases at Redeemer’s University, has been named on the 2025 TIME100 list, TIME magazine’s annual ranking of ...

Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in ...

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

A Series in The Lancet Neurology provides state-of-the-art reviews covering clinical and scientific evidence on the four most common genetic subtypes of amyotrophic lateral sclerosis (ALS), caused by ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Because RNAs are so central to our biology, they are also drivers of a wide array of diseases. Defects in how RNA is produced ...

Hantavirus, which is rare, shot to public attention after a New Mexico medical examiner announced that Gene Hackman’s wife Betsy Arakawa had died after contracting the virus. The bodies of ...

Using multiple techniques previously validated by the authors, this study identified INTS12, a component of the Integrator complex involved in 3' processing of small nuclear RNAs U1 and U2, as a ...

The authors employed a high-throughput CRISPR screening strategy to knock down genes and assess their relevance in maintaining HIV latency. They had used a similar approach in two previous studies, ...